Alpine Global Management, LLC 89bio, Inc. Transaction History

Alpine Global Management, LLC

  • $346 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Aug 06, 2024
BUY
$15.06 - $19.41 $154,922 - $199,670
10,287 New
10,287 $158,000
Q3 2023

Nov 14, 2023
BUY
$15.06 - $19.41 $154,922 - $199,670
10,287 New
10,287 $159,000
Q4 2020

Feb 12, 2021
SELL
$23.16 - $28.08 $2.42 Million - $2.94 Million
-104,534 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$24.34 - $38.82 $2.54 Million - $4.06 Million
104,534 New
104,534 $2.68 Million

Others Institutions Holding ETNB

# of Institutions
175
Shares Held
125M
Call Options Held
84K
Put Options Held
941K
View Full List

About 89bio, Inc.

ETNB Quotes by TradingView
  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $491M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email